A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
about
Impact of Non-Pulmonary Visceral Metastases in the Prognosis and Practice of Metastatic Testicular Germ Cell TumorsPharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.Chemotherapy intensification in patients with advanced seminoma and adverse prognostic factors.
P2860
A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A risk-adapted study of cispla ...... multicenter prospective study.
@ast
A risk-adapted study of cispla ...... multicenter prospective study.
@en
type
label
A risk-adapted study of cispla ...... multicenter prospective study.
@ast
A risk-adapted study of cispla ...... multicenter prospective study.
@en
prefLabel
A risk-adapted study of cispla ...... multicenter prospective study.
@ast
A risk-adapted study of cispla ...... multicenter prospective study.
@en
P2093
P1433
P1476
A risk-adapted study of cispla ...... multicenter prospective study.
@en
P2093
Agnes Laplanche
Armelle Caty
Christine Chevreau
Frank Priou
Frederic Rolland
Jean-Pierre Malhaire
Lionnel Geoffrois
Marie-Stephanie Aubelle
Philippe Beuzeboc
Pierre Kerbrat
P304
P356
10.1016/J.EURURO.2013.09.004
P407
P577
2013-09-13T00:00:00Z